Related references
Note: Only part of the references are listed.Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Owen M. Woodward et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
Hirotaka Matsuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Mutations in Glucose Transporter 9 Gene SLC2A9 Cause Renal Hypouricemia
Hirotaka Matsuo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Drug transporters: Recent advances concerning BCRP and tyrosine kinase inhibitors
C. Lemos et al.
BRITISH JOURNAL OF CANCER (2008)
The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane
M. Huls et al.
KIDNEY INTERNATIONAL (2008)
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
Abbas Dehghan et al.
LANCET (2008)
Abcg2/Bcrp1 mediates the polarized transport of antiretroviral nucleosides abacavir and zidovudine
Guoyu Pan et al.
DRUG METABOLISM AND DISPOSITION (2007)
ABCG2: determining its relevance in clinical drug resistance
Robert W. Robey et al.
CANCER AND METASTASIS REVIEWS (2007)
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Role of BCRP 421C>A polymorphism on rosuvastatin pharynacokinetics in healthy Chinese males
Wei Zhang et al.
CLINICA CHIMICA ACTA (2006)
Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population
Keiko Maekawa et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells
T Takada et al.
DRUG METABOLISM AND DISPOSITION (2005)
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump
H Burger et al.
BLOOD (2004)
Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154
T Takada et al.
DRUG METABOLISM AND DISPOSITION (2004)
Functional analysis of SNPs variants of BCRP/ABCG2
C Kondo et al.
PHARMACEUTICAL RESEARCH (2004)
Akt signaling regulates side population cell phenotype via Bcrp1 translocation
M Mogi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria
JW Jonker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
